Population pharmacokinetics of levofloxacin in breastmilk in patients with rifampicin‐resistant tuberculosis

Documenti analoghi

• Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin‐resistant tuberculosis
  di: Megan Palmer, et al.
  Pubblicazione: (2025)
• What can pharmacokinetic modelling do for you? Rational design and interpretation of clinical studies
  di: Francis Williams Ojara, et al.
  Pubblicazione: (2024)
• Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy
  di: Shakir Atoyebi, et al.
  Pubblicazione: (2024)
• Physiologically based pharmacokinetic model combined with a clinical lactation study to determine doravirine concentrations in human breastmilk
  di: Lena van der Wekken‐Pas, et al.
  Pubblicazione: (2025)
• Effects of rifampicin on the pharmacokinetics and safety of carotegrast methyl in healthy subjects: A randomized 2 × 2 crossover study
  di: Hiromitsu Imai, et al.
  Pubblicazione: (2024)